1 year return (CAGR)
26.61%
Aurinia Pharmaceuticals Inc Exchange (NASDAQ, USD)
AUPH
16.13
-0.28 (-1.71%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
17.95%
5 year return (CAGR)
-2.33%
10 year return (CAGR)
22.91%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.15B
Price/Sales
6.89
Ent value
2.14B
Price/Book
3.49
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
6.83
PEG
-
Forward P/E
15.12
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 16.35 |
| Daily high | 16.35 |
| Daily low | 15.98 |
| Daily Volume | 942K |
| All-time high | 33.08 |
| 1y analyst estimate | 17.86 |
| Beta | 1.40 |
| EPS (TTM) | 2.35 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| AUPH | S&P500 | |
| Current price drop from All-time high | -51.24% | -2.63% |
| Highest price drop | -87.58% | -56.47% |
| Date of highest drop | 27 Dec 2022 | 9 Mar 2009 |
| Avg drop from high | -49.72% | -10.68% |
| Avg time to new high | 87 days | 12 days |
| Max time to new high | 1223 days | 1805 days |
News
